peter meldrum led biotech company myriad genetics year heart landmark court battle involving whether two gene associated breast cancer could patented died dec salt lake city spokesman company said cause head injury sustained fell playing touch football grandchild mr meldrum mark skolnick founded myriad genetics mr meldrum became chief executive next year taking small start publicly traded company time retired annual revenue million visible product time test mutation brca brca gene could indicate heightened risk breast ovarian cancer company granted patent gene working several partner isolated mary claire king university california berkeley traced particular chromosome patent company vigorously defended mr meldrum tenure enabled myriad monopolize testing mutation gene coalition group including association molecular pathology american civil liberty union challenged patent court arguing part human body could patented myriad monopoly stifling research inflating cost test preventing many woman getting tested june year back forth ruling lower court supreme court invalidated patent ruling human gene opposed created synthetically could patented naturally occurring dna segment product nature patent eligible merely isolated justice clarence thomas wrote court undisputed myriad create alter genetic information encoded brca brca gene time though company moving toward comprehensive genetic test developed test area like colon cancer rheumatoid arthritis peter durkee meldrum born june salt lake city benjamin grace durkee meldrum received bachelor degree chemical engineering university utah cross country team two year army radiological officer returned university graduate school receiving master degree business administration mr meldrum married catherine marie roper survives son christopher brother daniel three grandson started venture capital firm founder fund joined force dr skolnick genetics researcher professor university start myriad vision company saw paradigm shift medicine mr meldrum said inducted utah technology council hall fame shift treating disease preventing using newly emerging tool genetics told mark started myriad odds u successful one technology field mr meldrum recalled probably going go nowhere told fascinating science going fun response critic brca patent mr meldrum others argued ability secure patent vital encouraging biotech company pursue research obviously important myriad biotechnology agriculture industry reinforce fact get patent gene mr meldrum said appeal court ruled company favor case eventually went supreme court encourage innovation development product save life improve quality life cost issue argued letter editor printed new york time insurance made cost test time negligible woman company also patient assistance program paid much cost eligible woman million woman used company test point letter said addition work myriad mr meldrum served board art organization like ballet west noted philanthropic effort behalf art retiring chairman meldrum foundation family charity support art education humanitarian effort 